-transparent.png){kind=logo}
An ultra-low dose (10(-14) M) of opioid peptide [D-Ala2]methionine enkephalinamide (DAMEA) is found to exert an inhibitory effect on the production of reactive oxygen species (respiratory burst) in human neutrophils. The validity of this phenomenon has been verified in a series of studies that comprised 30 experiments. The inhibition has proved to be statistically significant (P less than 0.001). The dose-response dependence of the effect (10(-15)-10(-9) M) followed a characteristic biphasic pattern (with the maximum effect at ultra-low doses). An opioid antagonist, naloxone partially blocks the inhibitory effect, which indicates that the DAMEA action is at least partially mediated by opioid receptors.
S V Zaitsev, and
L A Sazanov, and
A A Koshkin, and
G F Sud'ina, and
S D Varfolomeev
March 1981,
European journal of pharmacology,
S V Zaitsev, and
L A Sazanov, and
A A Koshkin, and
G F Sud'ina, and
S D Varfolomeev
January 1979,
Proceedings of the Western Pharmacology Society,
S V Zaitsev, and
L A Sazanov, and
A A Koshkin, and
G F Sud'ina, and
S D Varfolomeev
September 1984,
Pharmacology, biochemistry, and behavior,
S V Zaitsev, and
L A Sazanov, and
A A Koshkin, and
G F Sud'ina, and
S D Varfolomeev
July 1989,
The American journal of physiology,
S V Zaitsev, and
L A Sazanov, and
A A Koshkin, and
G F Sud'ina, and
S D Varfolomeev
January 1980,
Psychopharmacology,
S V Zaitsev, and
L A Sazanov, and
A A Koshkin, and
G F Sud'ina, and
S D Varfolomeev
May 1987,
Brain research,
S V Zaitsev, and
L A Sazanov, and
A A Koshkin, and
G F Sud'ina, and
S D Varfolomeev
March 1994,
Agents and actions,
S V Zaitsev, and
L A Sazanov, and
A A Koshkin, and
G F Sud'ina, and
S D Varfolomeev
August 1978,
Life sciences,
S V Zaitsev, and
L A Sazanov, and
A A Koshkin, and
G F Sud'ina, and
S D Varfolomeev
May 1984,
Brain research,
S V Zaitsev, and
L A Sazanov, and
A A Koshkin, and
G F Sud'ina, and
S D Varfolomeev
September 1978,
The Journal of pharmacology and experimental therapeutics,
